4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-050028
Chairman and CEO bought 7,600 shares at an average $1.48 ($11,248)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-08-03 | Purchase | +3,200 | $1.47 | $4,704 | 10,813,671 | D |
| Niihara Yutaka Chairman and CEO | 2021-08-04 | Purchase | +2,800 | $1.48 | $4,144 | 10,816,471 | D |
| Niihara Yutaka Chairman and CEO | 2021-08-05 | Purchase | +1,600 | $1.50 | $2,400 | 10,818,071 | D |
| Open-market purchases · 7,600 sh · avg $1.48 · $11,248 | |||||||
Loading xslF345X03/doc4.xml…